Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37629449)
Watch
English
Inflammation in the intestinal tract: pathogenesis and treatment
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
3202957
retrieved
21 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Inflammation in the intestinal tract: pathogenesis and treatment
(English)
1 reference
stated in
Europe PubMed Central
PMCID
3202957
retrieved
21 August 2017
main subject
pathogenesis
0 references
inflammation
0 references
author name string
Richard S Blumberg
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
3202957
retrieved
21 August 2017
publication date
4 November 2009
1 reference
stated in
Europe PubMed Central
PMCID
3202957
retrieved
21 August 2017
published in
Digestive Diseases
1 reference
stated in
Europe PubMed Central
PMCID
3202957
retrieved
21 August 2017
volume
27
1 reference
stated in
Europe PubMed Central
PMCID
3202957
retrieved
21 August 2017
issue
4
1 reference
stated in
Europe PubMed Central
PMCID
3202957
retrieved
21 August 2017
page(s)
455-464
1 reference
stated in
Europe PubMed Central
PMCID
3202957
retrieved
21 August 2017
cites work
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202957
retrieved
23 August 2017
Certolizumab pegol for the treatment of Crohn's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202957
retrieved
23 August 2017
Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202957
retrieved
23 August 2017
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202957
retrieved
23 August 2017
Anti-interleukin-12 antibody for active Crohn's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202957
retrieved
23 August 2017
Infliximab for the treatment of fistulas in patients with Crohn's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202957
retrieved
23 August 2017
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202957
retrieved
1 September 2018
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3202957
retrieved
1 September 2018
Identifiers
DOI
10.1159/000235851
1 reference
stated in
Europe PubMed Central
PMCID
3202957
retrieved
21 August 2017
PMCID
3202957
1 reference
stated in
Europe PubMed Central
PMCID
3202957
retrieved
21 August 2017
PubMed ID
19897960
1 reference
stated in
Europe PubMed Central
PMCID
3202957
retrieved
21 August 2017
ResearchGate publication ID
38075167
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
